BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 15496431)

  • 1. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons.
    Jiang H; Mankodi A; Swanson MS; Moxley RT; Thornton CA
    Hum Mol Genet; 2004 Dec; 13(24):3079-88. PubMed ID: 15496431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear RNA foci in the heart in myotonic dystrophy.
    Mankodi A; Lin X; Blaxall BC; Swanson MS; Thornton CA
    Circ Res; 2005 Nov; 97(11):1152-5. PubMed ID: 16254211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophy associated expanded CUG repeat muscleblind positive ribonuclear foci are not toxic to Drosophila.
    Houseley JM; Wang Z; Brock GJ; Soloway J; Artero R; Perez-Alonso M; O'Dell KM; Monckton DG
    Hum Mol Genet; 2005 Mar; 14(6):873-83. PubMed ID: 15703191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huntington's disease--like 2 is associated with CUG repeat-containing RNA foci.
    Rudnicki DD; Holmes SE; Lin MW; Thornton CA; Ross CA; Margolis RL
    Ann Neurol; 2007 Mar; 61(3):272-82. PubMed ID: 17387722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on gene therapy in myotonic dystrophy type 1.
    Magaña JJ; Cisneros B
    J Neurosci Res; 2011 Mar; 89(3):275-85. PubMed ID: 21259315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ hybridization analysis of Dmpk mRNA in adult mouse tissues.
    Sarkar PS; Han J; Reddy S
    Neuromuscul Disord; 2004 Sep; 14(8-9):497-506. PubMed ID: 15336691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
    Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
    Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of MBNL and CELF mRNA transcripts in muscles with myotonic dystrophy.
    Nezu Y; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Neuromuscul Disord; 2007 Apr; 17(4):306-12. PubMed ID: 17331722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
    Klein AF; Gasnier E; Furling D
    Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy.
    Frisch R; Singleton KR; Moses PA; Gonzalez IL; Carango P; Marks HG; Funanage VL
    Mol Genet Metab; 2001; 74(1-2):281-91. PubMed ID: 11592825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy.
    Carango P; Noble JE; Marks HG; Funanage VL
    Genomics; 1993 Nov; 18(2):340-8. PubMed ID: 8288237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2.
    Mankodi A; Urbinati CR; Yuan QP; Moxley RT; Sansone V; Krym M; Henderson D; Schalling M; Swanson MS; Thornton CA
    Hum Mol Genet; 2001 Sep; 10(19):2165-70. PubMed ID: 11590133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of dystrophia myotonica type 1 pre-mRNA transcripts by artificial trans-splicing.
    Chen HY; Kathirvel P; Yee WC; Lai PS
    Gene Ther; 2009 Feb; 16(2):211-7. PubMed ID: 18923454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.
    de Haro M; Al-Ramahi I; De Gouyon B; Ukani L; Rosa A; Faustino NA; Ashizawa T; Cooper TA; Botas J
    Hum Mol Genet; 2006 Jul; 15(13):2138-45. PubMed ID: 16723374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2.
    Mankodi A; Teng-Umnuay P; Krym M; Henderson D; Swanson M; Thornton CA
    Ann Neurol; 2003 Dec; 54(6):760-8. PubMed ID: 14681885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myotonic dystrophy 1 in the nervous system: from the clinic to molecular mechanisms.
    de León MB; Cisneros B
    J Neurosci Res; 2008 Jan; 86(1):18-26. PubMed ID: 17549748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect on gene expression of the expanded CTG repeat on 3'-untranslated region of myotonic dystrophy (DM) protein kinase].
    Furuya H; Imai N; Shiokawa K; Kira J
    Nihon Rinsho; 1999 Apr; 57(4):932-6. PubMed ID: 10222793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.